Pipecolinic acid 4-hydroxylase and method for producing 4-hydroxy amino acid using same

US2016348081A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016348081-A1
Application numberUS-201515115028-A
CountryUS
Kind codeA1
Filing dateJan 27, 2015
Priority dateJan 31, 2014
Publication dateDec 1, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce trans-4-hydroxy-L-pipecolic acid, and a method for producing 4-hydroxy amino acid, which method comprises reacting the pipecolic acid 4-hydroxylase protein, cells containing the protein, a treated product of the cells, and/or a culture liquid obtained by culturing the cells, with α-amino acid to produce 4-hydroxy amino acid: (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and (C) a polypeptide having an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity.

First claim

Opening claim text (preview).

1 . A pipecolic acid 4-hydroxylase protein having an activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions, to produce trans-4-hydroxy-L-pipecolic acid. 2 . The pipecolic acid 4-hydroxylase protein according to claim 1 , selected from the group consisting of the following (A), (B), and (C): (A) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18; (B) a polypeptide comprising the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18 except that one or several amino acids are deleted, substituted, and/or added, and having pipecolic acid 4-hydroxylase activity; and (C) a polypeptide comprising an amino acid sequence that is not less than 80% identical to the amino acid sequence represented by SEQ ID NO:2, 4, 6, 8, 10, 12, 16, or 18, and having pipecolic acid 4-hydroxylase activity. 3 . The pipecolic acid 4-hydroxylase protein according to claim 2 , which is produced as a recombinant protein by a host having no glycosylation ability. 4 . A method for producing 4-hydroxy amino acid, said method comprising reacting said pipecolic acid 4-hydroxylase protein according to claim 1 , a cell(s) comprising said protein, a treated product of said cell(s), and/or a culture liquid obtained by culturing said cell(s), with α-amino acid to produce 4-hydroxy amino acid. 5 . The method for producing 4-hydroxy amino acid according to claim 4 , wherein said α-amino acid is represented by the following General Formula (I): (wherein each of R 1 , R 2 , and R 5 represents a hydrogen atom or C 1 -C 3 alkyl; each of R 3 and R 4 represents a hydrogen atom, C 1 -C 3 alkyl, or hydroxyl; and alternatively R 2 may bind to R 5 or the nitrogen atom of the amino group to form a ring structure), and said 4-hydroxy amino acid is represented by the following General Formula (II): (wherein each of R 1 , R 2 , and R 5 represents a hydrogen atom or C 1 -C 3 alkyl; each of R 3 and R 4 represents a hydrogen atom, C 1 -C 3 alkyl, or hydroxyl; and alternatively R 2 may bind to R 5 or the nitrogen atom of the amino group to form a ring structure). 6 . The method for producing 4-hydroxy amino acid according to claim 4 , wherein said α-amino acid is pipecolic acid, and said 4-hydroxy amino acid is 4-hydroxy-L-pipecolic acid. 7 . The method for producing 4-hydroxy amino acid according to claim 4 , wherein said cell comprising pipecolic acid 4-hydroxylase is a cell transformed with a DNA encoding pipecolic acid 4-hydroxylase protein. 8 . The method for producing 4-hydroxy amino acid according to claim 7 , wherein said DNA encoding pipecolic acid 4-hydroxylase protein is selected from the group consisting of the following (D), (E), and (F): (D) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17; (E) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 except that one or several nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity; and (F) a DNA comprising a nucleotide sequence which hybridizes with the complementary strand of the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 under stringent conditions, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity. 9 . A microorganism transformed with a DNA encoding a pipecolic acid 4-hydroxylase protein selected from the group consisting of the following (D), (E), and (F): (D) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17; (E) a DNA comprising the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 except that one or several nucleotides are substituted, deleted, and/or added, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity; and (F) a DNA comprising a nucleotide sequence which hybridizes with the complementary strand of the nucleotide sequence represented by SEQ ID NO:1, 3, 5, 7, 9, 11, 15, or 17 under stringent conditions, and encoding a polypeptide having pipecolic acid 4-hydroxylase activity. 10 . The microorganism according to claim 9 , which is selected from the group consisting of the genera Escherichia, Bacillus, Pseudomonas , and Corynebacterium.

Assignees

Inventors

Classifications

  • Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

  • C12N9/0071Primary

    acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title

  • containing a six-membered hetero ring · CPC title

  • Nitrogen as only ring hetero atom · CPC title

  • Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016348081A1 cover?
The present invention provides a pipecolic acid 4-hydroxylase protein exemplified by the following (A), (B), and (C), having activity to react with L-pipecolic acid in the presence of 2-oxoglutaric acid and iron(II) ions to produce trans-4-hydroxy-L-pipecolic acid, and a method for producing 4-hydroxy amino acid, which method comprises reacting the pipecolic acid 4-hydroxylase protein, cells co…
Who is the assignee on this patent?
Api Corp
What technology area does this patent fall under?
Primary CPC classification C12N9/0071. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Dec 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).